EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes of a Novel Surgery: Gastrojejunal–Ileal Interposition with Bipartition and Sleeve Gastrectomy for Type 2 Diabetes and Obesity

Tugrul Demirel iD, Necdet Sut, Surendra Ugale

Journal of Clinical Medicine · 22.05.2026 · 15 (11) · 4027

DOI: 10.3390/jcm15114027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.05.2026. Verfasst von Tugrul Demirel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Faculty of Medicine, Trakya University, Edirne 22030, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Gastrojejunal–ileal interposition with bipartition and sleeve gastrectomy (GJIB-SG) is a novel metabolic procedure developed to combine functional foregut exclusion with hindgut stimulation while preserving duodenal continuity and endoscopic biliary access. This study evaluated the medium-term glycemic, weight-loss, and nutritional safety outcomes of GJIB-SG in patients with obesity and long-standing type 2 diabetes (T2D).

Methods

A retrospective single-center cohort of 30 consecutive patients with obesity and T2D who underwent GJIB-SG between January 2016 and August 2019 and reached at least 60 months of postoperative follow-up was analyzed at baseline and at 12, 24, 36, 48, and 60 months. Longitudinal data were analyzed by repeated-measures ANOVA with Greenhouse–Geisser correction and Bonferroni-adjusted pairwise comparisons. Diabetes remission was classified using the 2021 American Diabetes Association consensus definition (A1C < 6.5%, medication-free).

Results

Mean body weight decreased from 102.4 ± 13.6 kg preoperatively to 73.5 ± 7.6 kg at 60 months (p < 0.001; mean %TWL 27.4%, mean %EWL 99.4%). Mean A1C decreased from 9.4 ± 1.6% to 6.0 ± 1.4% at 60 months (p < 0.001). Complete medication-free remission was achieved by 70.0% of patients at 12 months and 44.8% at 60 months; cumulatively, 25 of 30 (83.3%) achieved complete remission at one or more intervals, and 3 patients (10.0%) never achieved A1C < 6.5%. Triglycerides, total cholesterol, and LDL cholesterol decreased by 56%, 39%, and 35%, respectively. No protein–energy malnutrition or hypoalbuminemia occurred; however, a late rise in parathyroid hormone and a return of 25-OH vitamin D toward preoperative insufficient values by 60 months indicate the need for sustained micronutrient surveillance. One cardiovascular death at 24 months was not considered procedure related.

Conclusions

In this single-center cohort, GJIB-SG was associated with durable weight loss, sustained glycemic improvement with cumulative complete remission in 83.3% of patients, and absence of severe nutritional complications over 60 months. Prospective comparative studies with longitudinal mixed-effects analysis are warranted to define the role of GJIB-SG within the metabolic–surgical armamentarium.

Schlagwörter

Stichwörter der Autor:innen

bariatric surgerydiabetes remissiongastrojejunal–ileal interpositionmetabolic surgerytype 2 diabetes

Autor:innen und Institutionen

  • Department of General Surgery, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
  • Department of Biostatistics and Medical Informatics, Faculty of Medicine, Trakya University, Edirne 22030, Turkey.
  • Department of Advanced Laparoscopy & Bariatric-Metabolic Surgery, Kirloskar Hospital, Hyderabad 500004, India.

ORCID-Profile: Tugrul Demirel

Zitieren

APA

Demirel, T., Sut, N., & Ugale, S. (2026). Outcomes of a Novel Surgery: Gastrojejunal–Ileal Interposition with Bipartition and Sleeve Gastrectomy for Type 2 Diabetes and Obesity. Journal of Clinical Medicine, 15(11), 4027. https://doi.org/10.3390/jcm15114027

Vancouver

Demirel T, Sut N, Ugale S. Outcomes of a Novel Surgery: Gastrojejunal–Ileal Interposition with Bipartition and Sleeve Gastrectomy for Type 2 Diabetes and Obesity. Journal of Clinical Medicine. 2026;15(11):4027. doi:10.3390/jcm15114027

BibTeX
@article{Demirel2026,
  author = {Demirel, Tugrul and Sut, Necdet and Ugale, Surendra},
  title = {Outcomes of a Novel Surgery: Gastrojejunal–Ileal Interposition with Bipartition and Sleeve Gastrectomy for Type 2 Diabetes and Obesity},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4027},
  doi = {10.3390/jcm15114027}
}
Kostenlos starten →